Efficacy and Safety of HLD200, a Novel Delayed-Release and Extended-Release Methylphenidate Formulation, in Children With Attention-Deficit/Hyperactivity Disorder: Results From a Pivotal Phase 3 Trial

Category Primary study
JournalPEDIATRICS
Year 2018
This article has no abstract
Epistemonikos ID: 281ece46a670c86f83790374e8132c1a44c069e6
First added on: Feb 11, 2025